To update and integrate the recommendations for ankylosing spondylitis and the recommendations
for the use of tumour necrosis factor inhibitors (TNFi) in axial spondyloarthritis (axSpA…

This first update of the ASAS/EULAR recommendations on the management of ankylosing
spondylitis (AS) is based on the original paper, a systematic review of existing …

Objectives To review and update the existing definition of a positive MRI for classification of
axial spondyloarthritis (SpA). Methods The Assessment in SpondyloArthritis International …

The field of spondyloarthritis (SpA) has experienced major progress in the last decade,
especially with regard to new treatments, earlier diagnosis, imaging technology and a better …

Background Secukinumab is an anti–interleukin-17A monoclonal antibody that has been
shown to control the symptoms of ankylosing spondylitis in a phase 2 trial. We conducted two …

Background: Magnetic resonance imaging (MRI) of sacroiliac joints has evolved as the most
relevant imaging modality for diagnosis and classification of early axial spondyloarthritis (…

Objective Ankylosing spondylitis (AS) is diagnosed late, because radiographs of the sacroiliac
joints often do not show definite sacroiliitis at the time of disease onset. The aim of this …

Objective To update the European League Against Rheumatism (EULAR) recommendations
for the pharmacological treatment of psoriatic arthritis (PsA). Methods According to the …

Objectives To update the Assessment of SpondyloArthritis international Society (ASAS)-EULAR
recommendations for the management of axial spondyloarthritis (axSpA). Methods …

Background Ankylosing spondylitis is a chronic immune-mediated inflammatory disease
characterised by spinal inflammation, progressive spinal rigidity, and peripheral arthritis. …